PH
Parnell Pharmaceuticals Holdings
PARNF
OTCHealth Care
Income Statement
Total Revenue$28.77M
Gross Profit$15.83M
Operating Income$-25.74M
EBITDA$-25.74M
EBIT$-25.74M
Pre-tax Income$-27.63M
Net Income$-31.26M
Balance Sheet
Net Cash$41.04M
Cash Equivalent$2.56M
Total Debt$10.75M
Net Debt$-30.29M
Book Value$2.91M
Net Cash Per Share3.09
Book Value Per Share0.44
Key Ratios
Return on Equity (ROE)-67.82%
Return on Assets (ROA)-29.73%
Return on Invested Capital (ROI)-36.41%
Net Profit Margin-104.31%
Current Ratio1.63
Quick Ratio1.25
Long-Term Debt / Equity0.71